S&P 500   4,305.20
DOW   34,152.01
QQQ   332.28
Companies facing 1st tax on stock buybacks in Biden bill
The Financial Day of Reckoning Has Begun (Ad)
Home Depot Results Point To Sluggish 2nd Half
Walmart Leads Retail Higher But Will The Group Follow? 
What's in big Biden bill? Health, climate goals become law
The Financial Day of Reckoning Has Begun (Ad)
Biden to sign massive climate and health care legislation
Stocks edge mostly higher on Wall Street; Walmart lifts Dow
US futures turn around on strong performance from retailers
MUST WATCH: Unusual 3-second financial maneuver (Ad)
S&P 500   4,305.20
DOW   34,152.01
QQQ   332.28
Companies facing 1st tax on stock buybacks in Biden bill
The Financial Day of Reckoning Has Begun (Ad)
Home Depot Results Point To Sluggish 2nd Half
Walmart Leads Retail Higher But Will The Group Follow? 
What's in big Biden bill? Health, climate goals become law
The Financial Day of Reckoning Has Begun (Ad)
Biden to sign massive climate and health care legislation
Stocks edge mostly higher on Wall Street; Walmart lifts Dow
US futures turn around on strong performance from retailers
MUST WATCH: Unusual 3-second financial maneuver (Ad)
S&P 500   4,305.20
DOW   34,152.01
QQQ   332.28
Companies facing 1st tax on stock buybacks in Biden bill
The Financial Day of Reckoning Has Begun (Ad)
Home Depot Results Point To Sluggish 2nd Half
Walmart Leads Retail Higher But Will The Group Follow? 
What's in big Biden bill? Health, climate goals become law
The Financial Day of Reckoning Has Begun (Ad)
Biden to sign massive climate and health care legislation
Stocks edge mostly higher on Wall Street; Walmart lifts Dow
US futures turn around on strong performance from retailers
MUST WATCH: Unusual 3-second financial maneuver (Ad)
S&P 500   4,305.20
DOW   34,152.01
QQQ   332.28
Companies facing 1st tax on stock buybacks in Biden bill
The Financial Day of Reckoning Has Begun (Ad)
Home Depot Results Point To Sluggish 2nd Half
Walmart Leads Retail Higher But Will The Group Follow? 
What's in big Biden bill? Health, climate goals become law
The Financial Day of Reckoning Has Begun (Ad)
Biden to sign massive climate and health care legislation
Stocks edge mostly higher on Wall Street; Walmart lifts Dow
US futures turn around on strong performance from retailers
MUST WATCH: Unusual 3-second financial maneuver (Ad)
ETR:FME

Fresenius Medical Care AG & Co. KGaA - FME Stock Forecast, Price & News

€37.30
+0.60 (+1.63%)
(As of 08/16/2022 12:00 AM ET)
Add
Compare
Today's Range
€36.78
€37.69
50-Day Range
€35.83
€54.16
52-Week Range
€35.08
€69.96
Volume
597,628 shs
Average Volume
704,197 shs
Market Capitalization
$10.94 billion
P/E Ratio
13.56
Dividend Yield
3.68%
Price Target
€52.15

Fresenius Medical Care AG & Co. KGaA MarketRank™ Forecast

Analyst Rating
N/A
0.00 Rating Score
Upside/​Downside
39.8% Upside
€52.15 Price Target
Short Interest
N/A
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-0.95
Upright™ Environmental Score
News Sentiment
1.22mentions of Fresenius Medical Care AG & Co. KGaA in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.65 out of 5 stars

FME stock logo

About Fresenius Medical Care AG & Co. KGaA (ETR:FME) Stock

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of February 23, 2022, it operated 4,171 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Receive FME Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fresenius Medical Care AG & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter.

FME Stock News Headlines

Fresenius Medical Care goes ex-dividend tomorrow
See More Headlines
Receive FME Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fresenius Medical Care AG & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter.

FME Company Calendar

Today
8/17/2022
Next Earnings (Estimated)
11/01/2022

Industry, Sector and Symbol

Industry
Medical Care
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
122,909
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
€52.15
High Stock Price Forecast
€75.00
Low Stock Price Forecast
€23.00
Forecasted Upside/Downside
+39.8%
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$18.39 billion
Cash Flow
€3.55 per share
Book Value
€47.88 per share

Miscellaneous

Free Float
N/A
Market Cap
$10.94 billion
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Robert Maurice Powell Jr. (Age 67)
    Chairman of the Management Board & CEO of Fresenius Medical Care Management AG
    Comp: $3.44M
  • Ms. Helen Giza (Age 54)
    Deputy CEO, Chief Transformation Officer, CFO & Member of Mgmt Board of Fresenius Med. Care Mgmt AG
    Comp: $1.78M
  • Dr. Franklin W. Maddux F.A.C.P. (Age 65)
    Global Chief Medical Officer & Member of Management Board of Fresenius Medical Care Management AG
    Comp: $1.59M
  • Mr. William J. Valle (Age 62)
    Management Board Member for Care Delivery of Fresenius Medical Care Management AG
    Comp: $3.93M
  • Dr. Katarzyna Mazur-Hofsab Ph.D. (Age 59)
    Management Board Member for Care Enablement of Fresenius Medical Care Management AG
    Comp: $4.37M
  • Mr. Roberto Fuste (Age 70)
    Exec. Advisor for Regional Strategy
  • Dr. Nwamaka Eneanya M.D.
    Head of Strategy & Operations
  • Dr. Dominik Heger
    Exec. VP and Head of Investor Relations, Strategic Devel. & Communications
  • Mr. Borries Von Muller (Age 61)
    Sr. VP of Global HR Employee Communications
  • Mr. Joachim Weith
    Sr. VP of Corp. Communications & Gov.al Affairs













FME Stock - Frequently Asked Questions

What is Fresenius Medical Care AG & Co. KGaA's stock price forecast for 2022?

0 Wall Street analysts have issued 1 year price objectives for Fresenius Medical Care AG & Co. KGaA's stock. Their FME share price forecasts range from €23.00 to €75.00. On average, they anticipate the company's share price to reach €52.15 in the next year. This suggests a possible upside of 42.1% from the stock's current price.
View analysts price targets for FME
or view top-rated stocks among Wall Street analysts.

How have FME shares performed in 2022?

Fresenius Medical Care AG & Co. KGaA's stock was trading at €57.14 on January 1st, 2022. Since then, FME shares have decreased by 35.8% and is now trading at €36.70.
View the best growth stocks for 2022 here
.

When is Fresenius Medical Care AG & Co. KGaA's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 1st 2022.
View our FME earnings forecast
.

Is Fresenius Medical Care AG & Co. KGaA a good dividend stock?

Fresenius Medical Care AG & Co. KGaA (ETR:FME) pays an annual dividend of €1.35 per share and currently has a dividend yield of 3.68%. The dividend payout ratio is 49.09%. This payout ratio is at a healthy, sustainable level, below 75%.

What other stocks do shareholders of Fresenius Medical Care AG & Co. KGaA own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Fresenius Medical Care AG & Co. KGaA investors own include Petra Diamonds (PDL), Fresenius Medical Care AG & Co. KGaA (FMS), RWE Aktiengesellschaft (RWE), Deutsche Lufthansa (LHA), Rio Tinto Group (RIO), Covestro (1COV), Carillion (CLLN), Nokia Oyj (NOK) and Oxford Biomedica (OXB).

What is Fresenius Medical Care AG & Co. KGaA's stock symbol?

Fresenius Medical Care AG & Co. KGaA trades on the ETR under the ticker symbol "FME."

What is Fresenius Medical Care AG & Co. KGaA's stock price today?

One share of FME stock can currently be purchased for approximately €36.70.

How much money does Fresenius Medical Care AG & Co. KGaA make?

Fresenius Medical Care AG & Co. KGaA (ETR:FME) has a market capitalization of $10.77 billion and generates $18.39 billion in revenue each year.

How many employees does Fresenius Medical Care AG & Co. KGaA have?

The company employs 122,909 workers across the globe.

How can I contact Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA's mailing address is Else-Kroener-Strasse 1, BAD HOMBURG, 61352, Germany. The official website for the company is www.freseniusmedicalcare.com. The company can be reached via phone at +49-6172-6090.

This page (ETR:FME) was last updated on 8/17/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.